Startups channel feed

Johns Hop­kins sci­en­tists raise $137M megaround for a trio of spin­outs look­ing to tack­le Alzheimer’s, Parkin­son’s and fi­bro­sis

6 years ago
Financing

Biotech tar­get­ing rare heart mu­ta­tion with gene ther­a­py scores $11M in Se­ries A haul

6 years ago
Financing
R&D

IBD start­up Lan­dos lands $60M Se­ries B in first test case of Chris Garabe­di­an's lean and mean mod­el at Xon­toge­ny

6 years ago
Financing

Alexan­dria seals $143M deal in Seat­tle's 'heart of the heart,' grab­bing cov­et­ed land to build its biotech clus­ter

6 years ago

Part pro­ce­dure, part drug: Robert Ang joins Sid­dhartha Mukher­jee in pi­o­neer­ing a new type of cell en­gi­neer­ing

6 years ago
People
Cell/Gene Tx

Biotech start­up joins quest to har­ness mi­cro­bio­me to un­teth­er re­liance on an­tibi­otics in wom­en's health

6 years ago

Backed by No­vo and Or­biMed, Thier­ry Abri­b­at hauls in $75M for biotech #3 — a transat­lantic up­start fo­cused on rare dis­eases

6 years ago
People

Laser-fo­cused on col­orec­tal can­cer test, Freenome wins $160M from mar­quee VC pack led by RA, Po­laris

6 years ago
Financing

No­var­tis backs Har­vard spin­out's quest to build TCR repos­i­to­ry in $48M round

6 years ago
Financing

Chardan's blank check com­pa­ny picks mi­cro­bio­me play­er Bio­mX for $70M re­verse merg­er

6 years ago

Backed by some of the biggest names in biotech, Nor­bert Bischof­berg­er gets his megaround for plat­form tech out of MIT

6 years ago
Financing

Bay­er, Long­wood back star re­searcher's deep dive in­to the tu­mor mi­croen­vi­ron­ment for new I/O tar­gets

6 years ago
Financing

Go­ing in­side cells, Sung Joo Lee has sketched some big goals for his small — but glob­al — team of drug hunters

6 years ago
R&D

San Diego oph­thalmic biotech up­start rais­es $28M on al­ter­na­tive to corneal trans­plant

6 years ago
Financing

Pe­ter Kolchin­sky and Raj Shah raise a $300M fund de­vot­ed to biotech star­tups

6 years ago
Financing

Can a Medicare Ad­van­tage in­sur­er be great at drug de­vel­op­ment for their tar­get au­di­ence?

6 years ago

Medicxi, Tai­ho in­fuse €30M in­to Evotec spin­out — eye­ing can­cer meds tar­get­ing DNA dam­age re­sponse path­ways

6 years ago
Financing

Tar­get­ing tox­ic pro­tein ag­gre­ga­tion, Ger­man biotech banks €12M to de­vel­op drug for rare neu­rode­gen­er­a­tive dis­or­der

6 years ago
Financing

Af­ter rais­ing $158M, this up­start's founders have star back­ers and plans to break new ground in gene ther­a­py

6 years ago
Financing
Cell/Gene Tx

Chris Var­ma un­veils MP­M's lat­est start­up — eye­ing 'un­drug­gable' can­cer tar­gets and pow­ered by ma­chine learn­ing, $67M

6 years ago
Financing

Ox­ford, Evotec ramp up LAB10x with AI ex­perts at Sen­syne — fo­cused on biotech spin­outs

6 years ago
AI

David de Graaf now has his $28.5M launch round in place, build­ing a coen­zyme A plat­form in his lat­est start­up

6 years ago
Financing

Philadel­phia cham­pi­ons life sci­ences 'co-work­ing,' re­viv­ing for­mer GSK cam­pus in $500M makeover

6 years ago

Adding mar­quee in­vestors, Black­Thorn bags $76M to back an AI-dri­ven strat­e­gy for pre­ci­sion neu­ro med­i­cine

6 years ago
Financing
First page Previous page 57585960616263 Next page Last page
A service from the Financial Times